79388966 - HANALL BIOPHARMA

Information

• Trademark
• 79388966

• Source

• Serial Number

  79388966

• Registration Number

  7617111

• International Classifications

  • 5 - Pharmaceutical and veterinary preparations
  • 35 - Advertising
  • 42 - Scientific and technological services and research and design relating thereto

• Filing Date

  November 16, 2023
  a year ago

• Registration Date

  December 24, 2024
  5 months ago

• Transaction Date

  March 26, 2025
  2 months ago

• Status Date

  December 24, 2024
  5 months ago

• Published for Opposition Date

  October 22, 2024
  7 months ago

• Location Date

  December 23, 2024
  5 months ago

• Status Code

  700

• Current Location

  FILE REPOSITORY (FRANCONIA)

  Employee Name

  JOHNSON, AISHA

• Attorney Name

  John M. Kim

• Owners

  • HANALL BIOPHARMA CO., LTD.

Case File Statements

• DM0000: The mark consists of the stylized wording HANALL BIOPHARMA in black, above the wording are three abstract designs of chromosomes in the colors green, yellow, and blue.
• GS0051: Reagents for use in diagnostic testing of Hepatitis B surface antibody for medical purposes and pharmaceutical agents affecting sensory organs; thyroid and para-thyroid hormone preparations; tonics, namely, medicines for autoimmune disease, ocular disease, ear disease, neurodegenerative disease, and cancer; anthelmintics; antiemetics; local anaesthetics; anti-cough drops; pituitary hormone preparations; pharmaceutical preparations for treating diabetes; pharmaceutical agents affecting metabolism; veterinary preparations for the treatment of autoimmune disease, ocular disease, ear disease, neurodegenerative disease, and cancer; prescription synthetic narcotics; anaesthetics; pharmaceutical agents affecting peripheral nervous system; pharmaceutical preparations for immunity improvement; pharmaceutical agents for treating physically caused lesions; pharmaceuticals for the treatment of erectile dysfunction; vesicants for wart removal; vaccines; adrenal hormone preparations; pharmaceutical preparations for the treatment of urogenital organs; vitamin preparations; pharmaceutical products for the treatment of bone diseases; crude medicines for the treatment of autoimmune disease, ocular disease, ear disease, neurodegenerative disease, and cancer; anti-inflammatory and antipyretic preparations; pharmaceutical agents affecting digestive organs; biological preparations for veterinary purposes for the treatment of autoimmune disease, ocular disease, ear disease, neurodegenerative disease, and cancer; chemical preparations for veterinary purposes for the treatment of autoimmune disease, ocular disease, ear disease, neurodegenerative disease, and cancer; cardiovascular pharmaceutical preparations; chemico-pharmaceutical preparations for the treatment of autoimmune disease, ocular disease, ear disease, neurodegenerative disease, and cancer; pharmaceutical agents for epidermis; medicines for the treatment of gastrointestinal diseases; diagnostic preparations for medical or veterinary purposes; drugs for medical purposes for the treatment of autoimmune disease, ocular disease, ear disease, neurodegenerative disease, and cancer; medical diagnostic reagents; diuretics; medicines for human purposes for the treatment of autoimmune disease, ocular disease, ear disease, neurodegenerative disease, and cancer; antacids; haematogen; pharmaceutical preparations for the treatment of tumours; pharmaceutical preparations acting on the central nervous system; analgesics; medical preparations for slimming purposes; medicines for dental purposes; dermatological pharmaceutical products; antibiotics; anti-cancer preparations; blood solvents for medical or veterinary purposes; pharmaceutical preparations for the treatment of respiratory organs; preparations for the treatment of burns; chemotherapeutics
• CC0000: The color(s) black, green, yellow and blue is/are claimed as a feature of the mark.
• GS0351: Price comparison services; distribution of samples; wholesale store services featuring nutraceuticals for use as a dietary supplement; retail store services featuring nutraceuticals for use as a dietary supplement; wholesale store services featuring medical apparatus; retail store services featuring medical apparatus; wholesale store services featuring medical apparatus and instruments; retail store services featuring medical apparatus and instruments; wholesale store services featuring pharmaceuticals; retail store services featuring pharmaceuticals; wholesale store services featuring medicines for human purposes; retail store services featuring medicines for human purposes; wholesale store services featuring fruit-based dietary supplements via the internet; retail store services featuring fruit-based dietary supplements via the internet; wholesale store services featuring make-up preparations via the internet; retail store services featuring make-up preparations via the internet; wholesale store services featuring nutraceuticals via the internet; retail store services featuring nutraceuticals via the internet; wholesale store services featuring make-up preparations; retail store services featuring make-up preparations
• DS0000: BIOPHARMA
• GS0421: Advice in the field of construction drafting; engineering surveying; rental of scientific equipment; research relating to mechanical engineering; meteorological observation for others; services for assessing the safety of agricultural chemicals; cosmetology research services; industrial design; pharmaceutical drug development services; pharmaceutical product evaluation; pharmaceutical research services; scientific research services in the fields of medicine, health and pharmacology; medical research; product safety testing; textile design; research in the field of computer software development; marine, aerial and land surveying; oceanography research; chemical analysis; scientific research in the nature of providing environmental impact surveys

Case File Event Statements

• 2/16/2024 - a year ago

  3 - APPLICATION FILING RECEIPT MAILED Type: MAFR

• 6/21/2024 - 11 months ago

  4 - ASSIGNED TO EXAMINER Type: DOCK

• 6/24/2024 - 11 months ago

  5 - NON-FINAL ACTION WRITTEN Type: CNRT

• 6/25/2024 - 11 months ago

  6 - NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW Type: RFCR

• 7/16/2024 - 10 months ago

  8 - NON-FINAL ACTION MAILED - REFUSAL SENT TO IB Type: RFCS

• 7/16/2024 - 10 months ago

  7 - REFUSAL PROCESSED BY MPU Type: RFRR

• 2/9/2024 - a year ago

  1 - SN ASSIGNED FOR SECT 66A APPL FROM IB Type: REPR

• 2/12/2024 - a year ago

  2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS

• 9/6/2024 - 8 months ago

  12 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME

• 9/6/2024 - 8 months ago

  11 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA

• 9/6/2024 - 8 months ago

  10 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA

• 9/12/2024 - 8 months ago

  13 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA

• 8/4/2024 - 9 months ago

  9 - REFUSAL PROCESSED BY IB Type: RFNT

• 10/2/2024 - 7 months ago

  14 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP

• 10/22/2024 - 7 months ago

  15 - PUBLISHED FOR OPPOSITION Type: PUBO

• 10/22/2024 - 7 months ago

  16 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB

• 12/24/2024 - 5 months ago

  17 - REGISTERED-PRINCIPAL REGISTER Type: R.PR

• 12/24/2024 - 5 months ago

  18 - NOTICE OF REGISTRATION CONFIRMATION EMAILED Type: NRCC

• 3/25/2025 - 2 months ago

  19 - FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB Type: FICR